Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Sees Significant Decrease in Short Interest

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) was the recipient of a large decline in short interest in September. As of September 30th, there was short interest totalling 3,000 shares, a decline of 6.3% from the September 15th total of 3,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 30.0 days.

Kissei Pharmaceutical Price Performance

OTCMKTS:KSPHF opened at $25.00 on Thursday. Kissei Pharmaceutical has a twelve month low of $19.32 and a twelve month high of $25.00. The business has a 50 day moving average price of $22.32 and a two-hundred day moving average price of $21.65.

Kissei Pharmaceutical Company Profile

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.